Literature DB >> 29613931

Comparison of Autograft and Allograft with Surface Modification for Flexor Tendon Reconstruction: A Canine in Vivo Model.

Zhuang Wei1, Ramona L Reisdorf1, Andrew R Thoreson1, Gregory D Jay2, Steven L Moran1, Kai-Nan An1, Peter C Amadio1, Chunfeng Zhao1.   

Abstract

BACKGROUND: Flexor tendon injury is common, and tendon reconstruction is indicated clinically if the primary repair fails or cannot be performed immediately after tendon injury. The purpose of the current study was to compare clinically standard extrasynovial autologous graft (EAG) tendon and intrasynovial allogeneic graft (IAG) that had both undergone biolubricant surface modification in a canine in vivo model.
METHODS: Twenty-four flexor digitorum profundus (FDP) tendons from the second and fifth digits of 12 dogs were used for this study. In the first phase, a model of failed FDP tendon repair was created. After 6 weeks, the ruptured FDP tendons with a scarred digit were reconstructed with the use of either EAG or IAG tendons treated with carbodiimide-derivatized hyaluronic acid and lubricin. At 12 weeks after tendon reconstruction, the digits were harvested for functional, biomechanical, and histologic evaluations.
RESULTS: The tendon failure model was a clinically relevant and reproducible model for tendon reconstruction. The IAG group demonstrated improved digit function with decreased adhesion formation, lower digit work of flexion, and improved graft gliding ability compared with the EAG group. However, the IAG group had decreased healing at the distal tendon-bone junction. Our histologic findings verified the biomechanical evaluations and, further, showed that cellular repopulation of allograft at 12 weeks after reconstruction is still challenging.
CONCLUSIONS: FDP tendon reconstruction using IAG with surface modification has some beneficial effects for reducing adhesions but demonstrated inferior healing at the distal tendon-bone junction compared with EAG. These mixed results indicate that vitalization and turnover acceleration are crucial to reducing failure of reconstruction with allograft. CLINICAL RELEVANCE: Flexor tendon reconstruction is a common surgical procedure. However, postoperative adhesion formation may lead to unsatisfactory clinical outcomes. In this study, we developed a potential flexor tendon allograft using chemical and tissue-engineering approaches. This technology could improve function following tendon reconstruction.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29613931      PMCID: PMC6372221          DOI: 10.2106/JBJS.17.00925

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  41 in total

Review 1.  Development of flexor tendon surgery: twenty-five years of progress.

Authors:  J W Strickland
Journal:  J Hand Surg Am       Date:  2000-03       Impact factor: 2.230

2.  Effect of paratenon and repetitive motion on the gliding resistance of tendon of extrasynovial origin.

Authors:  Toshimitsu Momose; Peter C Amadio; Mark E Zobitz; Chunfeng Zhao; Kai-Nan An
Journal:  Clin Anat       Date:  2002-05       Impact factor: 2.414

3.  Staged flexor tendon reconstruction fingertip to palm.

Authors:  Michael P Coyle; Timothy P Leddy; Joseph P Leddy
Journal:  J Hand Surg Am       Date:  2002-07       Impact factor: 2.230

4.  Intrinsic mitogenic potential of canine flexor tendons.

Authors:  F J Duffy; J G Seiler; C A Hergrueter; J Kandel; R H Gelberman
Journal:  J Hand Surg Br       Date:  1992-06

Review 5.  Clinical outcomes associated with flexor tendon repair.

Authors:  Jin Bo Tang
Journal:  Hand Clin       Date:  2005-05       Impact factor: 1.907

6.  Effect of synergistic wrist motion on adhesion formation after repair of partial flexor digitorum profundus tendon lacerations in a canine model in vivo.

Authors:  Chunfeng Zhao; Peter C Amadio; Toshimitsu Momose; Paulus Couvreur; Mark E Zobitz; Kai-Nan An
Journal:  J Bone Joint Surg Am       Date:  2002-01       Impact factor: 5.284

7.  Epidemiology of hand injuries in a middle-sized city in southern Sweden: a retrospective comparison of 1989 and 1997.

Authors:  Hans-Eric Rosberg; Lars B Dahlin
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  2004

8.  Flexor tendon grafting to the hand: an assessment of the intrasynovial donor tendon-A preliminary single-cohort study.

Authors:  F J Leversedge; D Zelouf; C Williams; R H Gelberman; J G Seiler
Journal:  J Hand Surg Am       Date:  2000-07       Impact factor: 2.230

9.  Two-stage grafting of digital flexor tendons: a review of 43 patients after 3 to 15 years.

Authors:  Vilhjalmur Finsen
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  2003

10.  Digital resistance and tendon strength during the first week after flexor digitorum profundus tendon repair in a canine model in vivo.

Authors:  Chunfeng Zhao; Peter C Amadio; Philippe Paillard; Tatsuro Tanaka; Mark E Zobitz; Dirk R Larson; Kai-Nan An
Journal:  J Bone Joint Surg Am       Date:  2004-02       Impact factor: 5.284

View more
  3 in total

Review 1.  From the perspective of embryonic tendon development: various cells applied to tendon tissue engineering.

Authors:  Fangjie Qi; Zhantao Deng; Yuanchen Ma; Shuai Wang; Chang Liu; Fengjuan Lyu; Tao Wang; Qiujian Zheng
Journal:  Ann Transl Med       Date:  2020-02

2.  Tension Stimulation of Tenocytes in Aligned Hyaluronic Acid/Platelet-Rich Plasma-Polycaprolactone Core-Sheath Nanofiber Membrane Scaffold for Tendon Tissue Engineering.

Authors:  Chih-Hao Chen; Dai-Ling Li; Andy Deng-Chi Chuang; Banendu Sunder Dash; Jyh-Ping Chen
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

3.  Impact of Electrospun Piezoelectric Core-Shell PVDFhfp/PDMS Mesh on Tenogenic and Inflammatory Gene Expression in Human Adipose-Derived Stem Cells: Comparison of Static Cultivation with Uniaxial Cyclic Tensile Stretching.

Authors:  Walter Baumgartner; Petra Wolint; Silvan Hofmann; Cléa Nüesch; Maurizio Calcagni; Marzia Brunelli; Johanna Buschmann
Journal:  Bioengineering (Basel)       Date:  2022-01-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.